
James B. Renacci sold Prothena Corporation plc (NASDAQ: PRTA)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 6 trades in Prothena Corporation plc (PRTA) since 2015, 4 purchases and 2 sales, worth an estimated $48K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $1,001 - $15,000 of Prothena Corporation plc (NASDAQ: PRTA) on December 13, 2016. Since that trade, PRTA is down -83.78% against the S&P 500 up +273.15%, an outperformance of -356.93%.
Across these filings, James B. Renacci has been a net buyer of PRTA (a buy-to-sell ratio of 2.00). The most recent disclosed PRTA transaction shown was dated December 15, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's PRTA trades vs the price
PRTA is down -83.78% since James B. Renacci sold on December 13, 2016, versus +273.15% for the S&P 500.
Performance since this trade
All James B. Renacci PRTA trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & PRTA trading FAQ
Is it legal for James B. Renacci to trade Prothena Corporation plc (PRTA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Prothena Corporation plc (PRTA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell PRTA?
James B. Renacci disclosed a sale of $1,001 - $15,000 of Prothena Corporation plc (PRTA) on December 13, 2016, according to public STOCK Act filings.
How has PRTA performed since James B. Renacci's trade?
Since James B. Renacci sold PRTA on December 13, 2016, the stock is down -83.78%, versus +273.15% for the S&P 500 over the same period, an outperformance of -356.93%.
How many times has James B. Renacci traded PRTA?
James B. Renacci has disclosed 6 PRTA trades since 2015 (4 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional PRTA trades?
Quantellect tracks every disclosed congressional trade in Prothena Corporation plc (PRTA) on the Prothena Corporation plc congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's PRTA tradesAll congressional filings for Prothena Corporation plcJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

